The global Softgel Capsule Market, valued at USD 1.28 billion in 2024, is projected to reach USD 2.07 billion by 2032, growing at a CAGR of 6.17% from 2025 to 2032. This growth is driven by rising demand for dietary supplements, increasing prevalence of chronic diseases, and consumer preference for easy-to-swallow, bioavailable dosage forms. Advancements in encapsulation technology, 3D capsule printing, and sustainable, plant-based softgel formulations are transforming the pharmaceutical and nutraceutical industries. North America dominates the market, while Asia-Pacific is witnessing rapid expansion due to increasing health awareness and supplement consumption.